The International Association for Biologicals (IABS), InB:Biotechnologies, Inc. and the Fraunhofer USA Center for Molecular Biotechnology invite you to participate in the upcoming New Cells for New Vaccines III workshop.
The workshop will focus on scientific, clinical, regulatory and manufacturing issues associated with the use of non-conventional cell substrates for the development and production of vaccines.
Workshop Overview
A key aspect of the success and viability of a vaccine development project is the choice of an appropriate cell substrate. The past fifty years have seen a dramatic increase in the types of cells available for vaccine production. Nevertheless, there remains a need for new and innovative approaches to extend the range of vaccines available for the protection of human and animal health.
Recent developments involving cells of insect and plant origin are attracting considerable scientific interest. Presentations at the last two New Cells for New Vaccines workshops included development of influenza vaccines in plants, clinical trials of an HPV vaccine produced with the BEVS in insect cells and antibody expression in microalgae.
New Cells for New Vaccines III will be of interest to scientists in the biotechnology and pharmaceutical industry involved in vaccine development and production, as well as academics, regulatory and public health authorities, and medical and veterinary experts.
Late Poster Abstracts
Late submission of abstracts for poster presentation are invited. Your abstract should contain sufficient information for the International Program Committee to determine its relevance to the aims of the workshop. Please submit a title and abstract for consideration to: Dr. Geoffrey Schild at gschild@inb-biotechnologies.com.
